Ascend Capital’s Cigna CI Stock Holding History

Ascend Capital’s Portfolio CI Stock Details CI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	$37.5M	Buy	+180,249	New	+$33.4M	1.89%	10

Other funds holding CI

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

VAM

Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return

Ascend Capital's CI Position: Q3 2018 in Review

Ascend Capital opened a new position in Cigna (CI) in Q3 2018: 180,249 shares worth $37.5M. The stake represents 1.89% of the portfolio and ranks #10 among its holdings.

868 funds tracked by Wall St. Rank hold CI as of Q3 2018.

Ascend Capital held 180,249 shares of Cigna worth $37.5M as of Q3 2018.
Cigna was a new Ascend Capital position in Q3 2018.
Cigna made up 1.89% of Ascend Capital's portfolio in Q3 2018, its #10 holding.
868 funds tracked by Wall St. Rank held Cigna as of Q3 2018.

Based on Ascend Capital's 13F filing for Q3 2018, filed 13 Nov 2018.